Clinical Trials

NCT05064826 | ACTIVE_NOT_RECRUITING | NA

170 participants

ED Observation for Opioid Use Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2022-04-21

Completion:

2025-06-01

Conditions

• Opioid Use Disorder

Interventions

• OTHER

No Results Yet

NCT05058313 | COMPLETED | NA

25 participants

Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2022-03-29

Completion:

2023-06-13

Conditions

• Menopause
• Urinary Incontinence
• Atrophic Vaginitis

Interventions

• DEVICE

No Results Yet

NCT05030493 | ACTIVE_NOT_RECRUITING

787 participants

An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2021-08-31

Completion:

2027-07-31

Conditions

• Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT04991103 | RECRUITING | PHASE2

40 participants

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-09-22

Completion:

2027-01-01

Conditions

• Multiple Myeloma
• Amyloidosis

Interventions

• DRUG

No Results Yet

NCT04980092 | SUSPENDED

100 participants

Assessment of Kidney Function and Osteomuscular Status After Critical Care

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2023-03-01

Completion:

2026-03-31

Conditions

• Critical Illness
• Kidney Injury
• Muscle Loss
• Bone Loss

Interventions

• OTHER

No Results Yet

NCT04952779 | COMPLETED

750 participants

Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2021-06-02

Completion:

2024-12-15

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT04930445 | TERMINATED

265 participants

Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2022-02-04

Completion:

2024-10-10

Conditions

• Sickle Cell Disease

Interventions

• DRUG

Results Available

NCT04912505 | COMPLETED | PHASE2

4 participants

ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2023-01-16

Completion:

2024-01-02

Conditions

• Purpura, Thrombocytopenic

Interventions

• DRUG

No Results Yet

NCT04838743 | COMPLETED

244 participants

GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2021-04-23

Completion:

2022-10-26

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT04805788 | TERMINATED | PHASE2

9 participants

Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-08-24

Completion:

2024-02-15

Conditions

• Recurrent Hepatocellular Carcinoma
• Stage I Hepatocellular Carcinoma AJCC v8
• Stage II Hepatocellular Carcinoma AJCC v8
• Stage III Hepatocellular Carcinoma AJCC v8

Interventions

• RADIATION
• OTHER

No Results Yet

NCT04800484 | RECRUITING | NA

40 participants

The Effects of AFO Heel Height and Stiffness on Gait

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-11-07

Completion:

2027-01-01

Conditions

• Musculoskeletal Injury
• Musculoskeletal Diseases
• Peripheral Nervous System Diseases

Interventions

• DEVICE

No Results Yet

NCT04779957 | COMPLETED | PHASE2

18 participants

Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-10-01

Completion:

2024-08-09

Conditions

• Kidney Transplantation
• Graft Failure

Interventions

• DRUG

No Results Yet

NCT04763980 | RECRUITING | NA

72 participants

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-01-15

Completion:

2027-03-31

Conditions

• Prostate Carcinoma

Interventions

• OTHER

No Results Yet

NCT04737460 | ACTIVE_NOT_RECRUITING | PHASE1

4 participants

Study for the Treatment for CLN7 Disease

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-05-04

Completion:

2028-02-01

Conditions

• CLN7

Interventions

• GENETIC

No Results Yet

NCT04660487 | RECRUITING

100 participants

Relationship Between "FODMAPs" and "GVHD"

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2020-12-01

Completion:

2026-12-01

Conditions

• Graft Versus Host Disease

No Results Yet

NCT04601857 | TERMINATED | PHASE2

43 participants

Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-01-07

Completion:

2024-03-08

Conditions

• Advanced and Metastatic Urothelial Cancer

Interventions

• DRUG

Results Available

NCT04453917 | COMPLETED | NA

22 participants

Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2021-02-23

Completion:

2024-07-12

Conditions

• Progressive Multifocal Leukoencephalopathy

Interventions

• BIOLOGICAL
• DIAGNOSTIC_TEST

No Results Yet

NCT04451135 | ACTIVE_NOT_RECRUITING | NA

31 participants

CET- REM (Correlating ECT Response to EEG Markers)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-10-09

Completion:

2026-06-30

Conditions

• ECT
• Treatment Resistant Depression

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT04443660 | COMPLETED

97 participants

Autophagy/Apoptosis Balance During Pregnancy

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2020-12-30

Completion:

2024-09-30

Conditions

• Pregnancy Related

Interventions

• OTHER

No Results Yet

NCT04364217 | WITHDRAWN | NA

0 participants

Pain and Itch Reduction in Burn Scars Treated With Fractional CO2 Laser

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-06-25

Completion:

2025-03-31

Conditions

• Hypertrophic Scar
• Burn Scar

Interventions

• DEVICE

No Results Yet

NCT04356755 | RECRUITING | PHASE2

32 participants

Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-09-22

Completion:

2027-03-31

Conditions

• Systemic Sclerosis

Interventions

• DRUG

No Results Yet

NCT04353375 | RECRUITING | PHASE2/PHASE3

235 participants

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-09-03

Completion:

2028-06-30

Conditions

• Advanced Intrahepatic Cholangiocarcinoma
• Solid Tumor, Adult

Interventions

• DRUG

No Results Yet

NCT04311606 | COMPLETED | PHASE2

11 participants

Anti-VEGF Therapy for Acute Thyroid Eye Disease

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-11-02

Completion:

2024-12-17

Conditions

• Thyroid Eye Disease

Interventions

• DRUG

No Results Yet

NCT04307134 | COMPLETED

108 participants

Besponsa Post Marketing Surveillance Study

Study Type:

OBSERVATIONAL

Last Updated:

2025-12-31

Start Date:

2020-07-09

Completion:

2024-12-24

Conditions

• Hematologic Malignancy

Interventions

• DRUG

Results Available

NCT04227509 | COMPLETED | PHASE2

53 participants

Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-06-04

Completion:

2024-08-21

Conditions

• Nasopharyngeal Carcinoma

Interventions

• DRUG

No Results Yet

NCT04224337 | COMPLETED | PHASE2

16 participants

Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-06-11

Completion:

2023-08-14

Conditions

• Carcinoma, Non-Small-Cell Lung

Interventions

• DRUG

No Results Yet

NCT04203160 | TERMINATED | PHASE1/PHASE2

75 participants

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-06-23

Completion:

2024-04-16

Conditions

• Biliary Tract Cancer

Interventions

• DRUG

Results Available

NCT04192435 | COMPLETED | PHASE4

3300 participants

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2022-05-18

Completion:

2025-09-13

Conditions

• Infection Wound
• Gastrointestinal Complication
• Anesthesia
• Bleeding
• Healthcare Associated Infection

Interventions

• DRUG

No Results Yet

NCT04172922 | TERMINATED | PHASE1

5 participants

Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-04-01

Completion:

2024-02-15

Conditions

• Vascular Anomaly

Interventions

• DRUG

No Results Yet

NCT04141449 | ACTIVE_NOT_RECRUITING | PHASE2

874 participants

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-11-18

Completion:

2026-09-30

Conditions

• Neoplasms
• Hiv
• Cervical Cancer
• Breast Cancer
• HNSCC
• Vulvar Cancer
• Anal Cancer
• Cancer Suspect

Interventions

• OTHER

No Results Yet

NCT04124198 | ACTIVE_NOT_RECRUITING | NA

138 participants

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-03-01

Completion:

2025-12-16

Conditions

• Oropharynx Cancer
• Oropharynx Squamous Cell Carcinoma
• Carcinoma, Squamous Cell
• Carcinoma
• Oropharyngeal Neoplasms
• Neoplasms, Squamous Cell
• Neoplasms, Glandular and Epithelial
• Neoplasms by Histologic Type
• Pharyngeal Neoplasms Malignant and Unspecified
• Otorhinolaryngologic Neoplasms
• Head and Neck Neoplasms
• Neoplasms by Site
• Otorhinolaryngologic Diseases
• Pharyngeal Diseases
• Papillomavirus Infections
• Virus Diseases
• DNA Virus Infections
• Tumor Virus Infections
• Quality of Life

Interventions

• RADIATION
• DRUG
• PROCEDURE

No Results Yet

NCT04116905 | COMPLETED | NA

68 participants

Intensive Lifestyle Intervention for Remission of Metabolic Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-10-01

Completion:

2022-08-31

Conditions

• Metabolic Syndrome

Interventions

• BEHAVIORAL

No Results Yet

NCT04115319 | COMPLETED | PHASE3

305 participants

A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-11-21

Completion:

2022-12-30

Conditions

• Schizophrenia

Interventions

• DRUG

Results Available

NCT04091009 | WITHDRAWN | PHASE4

0 participants

Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-10-31

Completion:

2025-12-31

Conditions

• Opioid-use Disorder
• Opioid Use Disorder, Mild

Interventions

• DRUG

No Results Yet

NCT04064086 | ACTIVE_NOT_RECRUITING | NA

656 participants

Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2020-03-25

Completion:

2025-09-30

Conditions

• Chronic Kidney Disease
• End Stage Renal Disease
• Hemodialysis
• Peritoneal Dialysis

Interventions

• OTHER

No Results Yet

NCT03955185 | ACTIVE_NOT_RECRUITING | NA

2000 participants

Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-05-01

Completion:

2026-05-01

Conditions

• Uterine Cervical Neoplasm

Interventions

• PROCEDURE

No Results Yet

NCT03926117 | COMPLETED | PHASE2

264 participants

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-06-03

Completion:

2020-06-26

Conditions

• Chronic Kidney Diseases
• Inflammation

Interventions

• BIOLOGICAL

Results Available

NCT03844750 | TERMINATED | PHASE2

6 participants

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-07-22

Completion:

2025-09-30

Conditions

• Metastatic Malignant Neoplasm in the Liver
• Stage IV Colorectal Cancer AJCC v8
• Stage IVA Colorectal Cancer AJCC v8
• Stage IVB Colorectal Cancer AJCC v8
• Stage IVC Colorectal Cancer AJCC v8

Interventions

• PROCEDURE
• BIOLOGICAL
• DRUG

Results Available

NCT03840993 | COMPLETED | PHASE2

76 participants

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-01-15

Completion:

2021-05-13

Conditions

• Endometrial Related Pain

Interventions

• DRUG

Results Available

NCT03809039 | TERMINATED | PHASE1

52 participants

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2025-12-31

Start Date:

2019-01-15

Completion:

2019-07-01

Conditions

• Healthy

Interventions

• DRUG

Results Available